TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | 1 | 4 | -2 | 13 | 16 | 5 |
| S | %wins | 100 | 67 | 33 | 33 | 33 | 0 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/11 16:09 | 9/15/11 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | See rema | S.d | -304 | 60.76 | 33 | -5 | -9 | 53 | D | 12 | 10 | 13 | 4 | 9 | 7 | 2 | 0 | 0 | 4 | 9 | 3 | 24 | 25 |
9/16/11 16:09 | 9/15/11 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | See rema | M.d | 16 | 7.78 | 33 | 2 | 4 | 53 | D | 12 | 10 | 13 | 4 | 9 | 7 | 2 | 0 | 0 | 4 | 9 | 3 | 24 | 25 |
11/4/10 16:41 | 11/2/10 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | See rema | S.d | -633 | 63.28 | 33 | -10 | -15 | 56 | D | -4 | 23 | 8 | 12 | 10 | 8 | 5 | 1 | -2 | -1 | -3 | -21 | -6 | 2 |
11/4/10 16:41 | 11/2/10 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | See rema | M.d | 9 | 7.28 | 33 | 1 | 2 | 56 | D | -4 | 23 | 8 | 12 | 10 | 8 | 5 | 1 | -2 | -1 | -3 | -21 | -6 | 2 |
10/29/09 16:35 | 10/27/09 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | See rema | S | -2,070 | 52.23 | 33 | -40 | -38 | 65 | D | -24 | -17 | 18 | -13 | -5 | -7 | -11 | -7 | 0 | -1 | 7 | 11 | 21 | 20 |
6/9/09 16:35 | 6/5/09 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | See rema | M.d | 317 | 13.38 | 33 | 24 | 29 | 105 | D | -23 | -28 | -17 | 10 | 8 | 10 | 5 | -3 | -2 | -5 | 4 | 17 | 27 | 19 |
11/5/08 17:51 | 11/3/08 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | SVP,GRA, | M.d | 696 | 8.40 | 33 | 83 | 733 | 94 | D | 26 | 0 | 2 | -16 | 0 | 22 | 12 | 1 | -3 | -9 | -16 | -13 | -33 | -19 |
3/18/08 16:42 | 3/14/08 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Burton Graham | NJ | O | SVP,GRA, | M.d | 410 | 7.78 | 33 | 53 | 999% | 55 | D | 33 | 4 | -21 | 10 | -5 | -4 | -1 | -4 | 0 | 7 | 13 | 7 | 21 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |